Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Evolving concepts in the diagnosis, pathogenesis and treatment of autoimmune hepatitis.

Czaja AJ.

Minerva Gastroenterol Dietol. 2007 Mar;53(1):43-78. Review.

PMID:
17415344
2.

Autoimmune hepatitis. Part B: diagnosis.

Czaja AJ.

Expert Rev Gastroenterol Hepatol. 2007 Oct;1(1):129-43. doi: 10.1586/17474124.1.1.129. Review.

PMID:
19072441
3.

Diverse manifestations and evolving treatments of autoimmune hepatitis.

Czaja AJ.

Minerva Gastroenterol Dietol. 2005 Dec;51(4):313-33. Review.

PMID:
16282960
4.

Current concepts in autoimmune hepatitis.

Czaja AJ.

Ann Hepatol. 2005 Jan-Mar;4(1):6-24. Review.

PMID:
15798657
5.

Autoimmune hepatitis. Part A: pathogenesis.

Czaja AJ.

Expert Rev Gastroenterol Hepatol. 2007 Oct;1(1):113-28. doi: 10.1586/17474124.1.1.113. Review.

PMID:
19072440
6.

Progress in the diagnosis and treatment of autoimmune hepatitis.

Czaja AJ.

Minerva Med. 2008 Dec;99(6):549-68. Review.

PMID:
19034254
7.

Autoimmune liver disease.

Czaja AJ.

Curr Opin Gastroenterol. 2006 May;22(3):234-40. Review.

PMID:
16550037
8.

Autoimmune liver disease.

Czaja AJ.

Curr Opin Gastroenterol. 2005 May;21(3):293-9. Review.

PMID:
15818149
9.

Diagnosis and therapy of autoimmune hepatitis.

Granito A, Muratori P, Ferri S, Pappas G, Quarneti C, Lenzi M, Bianchi FB, Muratori L.

Mini Rev Med Chem. 2009 Jun;9(7):847-60. Review.

PMID:
19519509
10.

Autoimmune liver disease.

Czaja AJ.

Curr Opin Gastroenterol. 2003 May;19(3):232-42.

PMID:
15703563
11.

Emerging treatments for autoimmune hepatitis.

Czaja AJ.

Curr Drug Targets Inflamm Allergy. 2002 Dec;1(4):317-26. Review.

PMID:
14561179
12.

Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis.

Czaja AJ, Manns MP.

Gastroenterology. 2010 Jul;139(1):58-72.e4. doi: 10.1053/j.gastro.2010.04.053. Epub 2010 May 5. Review.

PMID:
20451521
13.

Special clinical challenges in autoimmune hepatitis: the elderly, males, pregnancy, mild disease, fulminant onset, and nonwhite patients.

Czaja AJ.

Semin Liver Dis. 2009 Aug;29(3):315-30. doi: 10.1055/s-0029-1233530. Epub 2009 Aug 12. Review.

PMID:
19676004
14.
15.

Treatment challenges and investigational opportunities in autoimmune hepatitis.

Czaja AJ, Bianchi FB, Carpenter HA, Krawitt EL, Lohse AW, Manns MP, McFarlane IG, Mieli-Vergani G, Toda G, Vergani D, Vierling J, Zeniya M.

Hepatology. 2005 Jan;41(1):207-15. Review.

PMID:
15690485
16.

Autoimmune liver disease.

Czaja AJ.

Curr Opin Gastroenterol. 2001 May;17(3):268-75.

PMID:
17031168
17.

Autoimmune liver disease and rheumatic manifestations.

Czaja AJ.

Curr Opin Rheumatol. 2007 Jan;19(1):74-80. Review.

PMID:
17143100
18.

Emerging opportunities for site-specific molecular and cellular interventions in autoimmune hepatitis.

Czaja AJ.

Dig Dis Sci. 2010 Oct;55(10):2712-26. doi: 10.1007/s10620-009-1122-8. Epub 2010 Jan 27. Review.

PMID:
20108036
19.

Autoimmune liver disease.

Czaja AJ.

Curr Opin Gastroenterol. 2009 May;25(3):215-22. doi: 10.1097/MOG.0b013e328324ed06. Review.

PMID:
19387256
20.

Treatment of autoimmune hepatitis: a review of current and evolving therapies.

Jothimani D, Cramp ME, Mitchell JD, Cross TJ.

J Gastroenterol Hepatol. 2011 Apr;26(4):619-27. doi: 10.1111/j.1440-1746.2010.06579.x. Review.

PMID:
21073674
Items per page

Supplemental Content

Write to the Help Desk